Abstract

The present study evaluates the performance of Baveno VI criteria, using liver stiffness (LS) assessed with a 2D-SWE elastography technique, for predicting high-risk varices (HRV) in patients with compensated advanced chronic liver disease (cACLD). A secondary aim was to determine whether the use of spleen stiffness measurements (SSMs), as additional criteria, increases the performance of the 2D-SWE Baveno VI criteria. Data were collected from 208 subjects with cACLD, who underwent abdominal ultrasound, liver and spleen stiffness measurements, and upper digestive endoscopy. HRV were defined as grade 1 esophageal varices (EV) with red wale marks, grade 2/3 EV, and gastric varices. A total of 35.6% (74/208) of the included subjects had HRV. The optimal LS cut-off value for predicting HRV was 12 kPa (AUROC-0.80). Using both LS cut-off value < 12 kPa and a platelet cut-off value > 150 × 109 cells/L as criteria to exclude HRV, 52/208 (25%) subjects were selected, 88.5% (46/52) were without EV, 9.6% (5/52) had grade 1 EV, and 1.9% (1/52) had HRV. Thus 98% of the subjects were correctly classified as having or not having HRV and 25% of the surveillance endoscopies could have been avoided. Using SS < 13.2 kPa and a platelet cut-off value > 150 × 109 cells/L as additional criteria for the patients that were outside the initial ones, 32.7% of the surveillance endoscopies could have been avoided.

Highlights

  • Assessing the status of portal hypertension (PH) with early and correct identification of patients at high risk of developing complications associated with PH, such as ascites, esophageal varices (EV), and EVen variceal bleeding is of the utmost importance [1]

  • The present study aims to EValuate the performance of Baveno VI criteria, using

  • Conclusions regarding the superiority of using a step-by-step algorithm or a multi-parametric approach are inconsistent among studies, but better performances were observed in the multi-parametric approaches as compared to their individual use [2,18,21,24]

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. The EValuation of portal hypertension (PH) in a non-invasive manner is an increasingly used approach and steps are being taken to identify new, reproducible, and widely available non-invasive markers. Assessing the status of PH with early and correct identification of patients at high risk of developing complications associated with PH, such as ascites, esophageal varices (EV), and EVen variceal bleeding is of the utmost importance [1]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call